• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OSTM1 双重功能在破骨细胞成熟中的作用:模仿人类 OSTM1 突变的小鼠模型的见解。

Ostm1 Bifunctional Roles in Osteoclast Maturation: Insights From a Mouse Model Mimicking a Human OSTM1 Mutation.

机构信息

Institut de Recherches Cliniques de Montréal (IRCM), Montréal, Québec, Canada.

Département de Médecine, Université de Montréal, Montréal, Québec, Canada.

出版信息

J Bone Miner Res. 2018 May;33(5):888-898. doi: 10.1002/jbmr.3378. Epub 2018 Feb 14.

DOI:10.1002/jbmr.3378
PMID:29297601
Abstract

Ostm1 mutations are responsible for the most severe form of osteopetrosis in human and mice. To gain insight into Ostm1 cellular functions, we engineered a conditional in-frame deletion of the Ostm1 transmembrane domain and generated the first Ostm1 mouse model with a human mutation. Systemic targeting of Ostm1 loss of transmembrane domain produced osteopetrosis, as in the null Ostm1 gl/gl mouse. Significantly, conditional osteoclast targeting of Ostm1 resulted in similar osteopetrosis, thereby demonstrating that the intrinsic Ostm1 osteoclast deficiency is solely responsible for the mouse phenotype. Our analysis showed oversized osteoclasts with enhanced multinucleation associated with stimulation of intracellular calcium levels, of Nfatc1 nuclear re-localization, and of specific downstream Nfatc1 target genes, providing compelling evidence that Ostm1 is a negative regulator of preosteoclast fusion. Moreover, mature OCs with Ostm1 loss of transmembrane domain show appropriate levels of intracellular acidification but an altered distribution pattern, highlighting misregulation of endolysosome localization and dispersion. Consistently, the hydrolases tartrate-resistant acid phosphatase (TRAP) and cathepsin K (Ctsk) normally produced are sequestered within the osteoclasts and are not extracellularly secreted. These studies defined bifunctional roles for Ostm1 as a major regulator of preosteoclast cytoskeletal rearrangements toward cell multinucleation and of mature osteoclast intracellular lysosomal trafficking and exocytosis mechanism, both of which are essential for bone resorption. Importantly, these Ostm1 molecular and regulatory functions could serve as preclinical targets in this mouse model toward osteoclastogenic pathologies as osteoporosis and inflammation-induced bone loss. © 2018 American Society for Bone and Mineral Research.

摘要

Ostm1 突变是导致人类和小鼠最严重形式的骨质增生症的原因。为了深入了解 Ostm1 的细胞功能,我们构建了 Ostm1 跨膜结构域的条件性框内缺失,并生成了具有人类突变的首个 Ostm1 小鼠模型。Ostm1 跨膜结构域缺失的系统性靶向导致了骨质增生症,就像 Ostm1 gl/gl 小鼠的缺失一样。重要的是,条件性破骨细胞靶向 Ostm1 导致了类似的骨质增生症,从而证明内在的 Ostm1 破骨细胞缺乏是小鼠表型的唯一原因。我们的分析表明,破骨细胞过大,多核化增强,与细胞内钙水平的刺激、Nfatc1 核重新定位以及特定下游 Nfatc1 靶基因有关,这提供了令人信服的证据,证明 Ostm1 是破骨前融合的负调节剂。此外,具有 Ostm1 跨膜结构域缺失的成熟 OC 显示出适当的细胞内酸化水平,但分布模式发生改变,突出了内溶酶体定位和分散的失调。一致地,正常产生的水解酶抗酒石酸酸性磷酸酶 (TRAP) 和组织蛋白酶 K (Ctsk) 被隔离在破骨细胞内,而不会分泌到细胞外。这些研究定义了 Ostm1 的双重功能,作为破骨前细胞骨架向多核化重排的主要调节剂,以及成熟破骨细胞细胞内溶酶体运输和胞吐机制的调节剂,这两者对于骨吸收都是必不可少的。重要的是,这些 Ostm1 分子和调节功能可以作为这种小鼠模型中的临床前靶点,用于骨质疏松症和炎症诱导的骨丢失等破骨细胞生成病理学。© 2018 美国骨骼与矿物质研究协会。

相似文献

1
Ostm1 Bifunctional Roles in Osteoclast Maturation: Insights From a Mouse Model Mimicking a Human OSTM1 Mutation.OSTM1 双重功能在破骨细胞成熟中的作用:模仿人类 OSTM1 突变的小鼠模型的见解。
J Bone Miner Res. 2018 May;33(5):888-898. doi: 10.1002/jbmr.3378. Epub 2018 Feb 14.
2
Secretion of a truncated osteopetrosis-associated transmembrane protein 1 (OSTM1) mutant inhibits osteoclastogenesis through down-regulation of the B lymphocyte-induced maturation protein 1 (BLIMP1)-nuclear factor of activated T cells c1 (NFATc1) axis.截短型骨硬化症相关跨膜蛋白1(OSTM1)突变体的分泌通过下调B淋巴细胞诱导成熟蛋白1(BLIMP1)-活化T细胞核因子c1(NFATc1)轴来抑制破骨细胞生成。
J Biol Chem. 2014 Dec 26;289(52):35868-81. doi: 10.1074/jbc.M114.589614. Epub 2014 Oct 30.
3
The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.小鼠骨石化灰色致死突变导致破骨细胞成熟/功能缺陷。
Bone. 2001 May;28(5):513-23. doi: 10.1016/s8756-3282(01)00416-1.
4
Ostm1 from Mouse to Human: Insights into Osteoclast Maturation.Ostm1 从鼠到人:破骨细胞成熟的见解。
Int J Mol Sci. 2020 Aug 5;21(16):5600. doi: 10.3390/ijms21165600.
5
The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity.树突状细胞特异性跨膜蛋白DC-STAMP对破骨细胞融合和破骨细胞骨吸收活性至关重要。
Mod Rheumatol. 2006;16(6):341-2. doi: 10.1007/s10165-006-0524-0. Epub 2006 Dec 20.
6
OSTM1 bone defect reveals an intercellular hematopoietic crosstalk.OSTM1骨缺损揭示了一种细胞间造血串扰。
J Biol Chem. 2008 Nov 7;283(45):30522-30. doi: 10.1074/jbc.M805242200. Epub 2008 Sep 11.
7
Clinical and cellular manifestations of OSTM1-related infantile osteopetrosis.与骨硬化蛋白1相关的婴儿骨硬化症的临床和细胞表现
J Bone Miner Res. 2008 Feb;23(2):296-300. doi: 10.1359/jbmr.071015.
8
C/ebpα controls osteoclast terminal differentiation, activation, function, and postnatal bone homeostasis through direct regulation of Nfatc1.C/ebpα 通过直接调节 NFATC1 来控制破骨细胞终末分化、激活、功能和出生后骨内稳态。
J Pathol. 2018 Mar;244(3):271-282. doi: 10.1002/path.5001. Epub 2018 Jan 29.
9
Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca /NFATc1 Axis.树突状细胞特异性跨膜蛋白(DC-STAMP)通过Ca²⁺/NFATc1轴调节破骨细胞分化。
J Cell Physiol. 2017 Sep;232(9):2538-2549. doi: 10.1002/jcp.25638. Epub 2017 Apr 12.
10
Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.常染色体显性遗传2型骨硬化症的疾病状态由破骨细胞特性决定。
J Bone Miner Res. 2006 Jul;21(7):1089-97. doi: 10.1359/jbmr.060409.

引用本文的文献

1
Molecular Mechanisms of Craniofacial and Dental Abnormalities in Osteopetrosis.骨硬化症中颅面和牙齿异常的分子机制。
Int J Mol Sci. 2023 Jun 20;24(12):10412. doi: 10.3390/ijms241210412.
2
Leucine Repeat Rich Kinase 1 Controls Osteoclast Activity by Managing Lysosomal Trafficking and Secretion.富含亮氨酸重复序列激酶1通过调控溶酶体运输与分泌来控制破骨细胞活性。
Biology (Basel). 2023 Mar 29;12(4):511. doi: 10.3390/biology12040511.
3
A signaling axis is a critical mediator of regulatory network in T lymphopoiesis.一条信号轴是T淋巴细胞生成调控网络的关键介质。
iScience. 2022 Mar 25;25(4):104160. doi: 10.1016/j.isci.2022.104160. eCollection 2022 Apr 15.
4
The Role of the Lysosomal Cl/H Antiporter ClC-7 in Osteopetrosis and Neurodegeneration.溶酶体 Cl-/H+ 反向转运蛋白 ClC-7 在骨质硬化症和神经退行性变中的作用。
Cells. 2022 Jan 21;11(3):366. doi: 10.3390/cells11030366.
5
Gene-metabolite networks associated with impediment of bone fracture repair in spaceflight.与航天飞行中骨折修复障碍相关的基因-代谢物网络
Comput Struct Biotechnol J. 2021 Jun 8;19:3507-3520. doi: 10.1016/j.csbj.2021.05.050. eCollection 2021.
6
Sorting Nexin 10 as a Key Regulator of Membrane Trafficking in Bone-Resorbing Osteoclasts: Lessons Learned From Osteopetrosis.分选连接蛋白10作为破骨细胞骨吸收过程中膜运输的关键调节因子:来自骨石化症的经验教训
Front Cell Dev Biol. 2021 May 20;9:671210. doi: 10.3389/fcell.2021.671210. eCollection 2021.
7
Osteoclast Fusion: Physiological Regulation of Multinucleation through Heterogeneity-Potential Implications for Drug Sensitivity.破骨细胞融合:通过异质性对多核形成的生理调节-对药物敏感性的潜在影响。
Int J Mol Sci. 2020 Oct 19;21(20):7717. doi: 10.3390/ijms21207717.
8
Learning from Monocyte-Macrophage Fusion and Multinucleation: Potential Therapeutic Targets for Osteoporosis and Rheumatoid Arthritis.从单核细胞-巨噬细胞融合和多核化中学习:骨质疏松症和类风湿关节炎的潜在治疗靶点。
Int J Mol Sci. 2020 Aug 20;21(17):6001. doi: 10.3390/ijms21176001.
9
Ostm1 from Mouse to Human: Insights into Osteoclast Maturation.Ostm1 从鼠到人:破骨细胞成熟的见解。
Int J Mol Sci. 2020 Aug 5;21(16):5600. doi: 10.3390/ijms21165600.
10
Cryo-EM structure of the lysosomal chloride-proton exchanger CLC-7 in complex with OSTM1.溶酶体氯离子-质子交换器 CLC-7 与 OSTM1 复合物的冷冻电镜结构。
Elife. 2020 Aug 4;9:e59555. doi: 10.7554/eLife.59555.